ES
GILD icon

Eagle Strategies’s Gilead Sciences GILD Stock Holding History

Eagle Strategies’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$408K Buy
3,232
+33
+1% +$4.35K 0.04% 207
2026
Q1 		$446K Buy
3,199
+40
+1% +$5.6K 0.05% 190
2025
Q4 		$388K Buy
3,159
+25
+0.8% +$3.04K 0.05% 192
2025
Q3 		$348K Buy
3,134
+19
+0.6% +$2.16K 0.05% 194
2025
Q2 		$345K Buy
3,115
+20
+0.6% +$2.13K 0.05% 175
2025
Q1 		$347K Buy
3,095
+4
+0.1% +$413 0.06% 163
2024
Q4 		$286K Buy
+3,091
New +$278K 0.05% 177
2024
Q3 		– Sell
-3,050
Closed -$209K – 213
2024
Q2 		$209K Sell
3,050
-149
-5% -$9.94K 0.04% 204
2024
Q1 		$234K Buy
3,199
+133
+4% +$10.2K 0.05% 239
2023
Q4 		$248K Buy
3,066
+43
+1% +$3.35K 0.05% 171
2023
Q3 		$227K Buy
3,023
+58
+2% +$4.46K 0.06% 168
2023
Q2 		$229K Buy
2,965
+4
+0.1% +$319 0.06% 172
2023
Q1 		$246K Buy
2,961
+4
+0.1% +$331 0.06% 159
2022
Q4 		$254K Buy
+2,957
New +$234K 0.08% 150

Other funds holding GILD

Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.94% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Eagle Strategies's GILD Position: Q2 2026 in Review

Eagle Strategies increased its Gilead Sciences (GILD) stake by 1% in Q2 2026, buying an estimated $4.35K and bringing the position to 3,232 shares worth $408K. The position accounts for 0.04% of the portfolio, ranked #207.

Eagle Strategies first reported a position in GILD in Q4 2022 and has held it in 14 quarters since. The position peaked at $446K in Q1 2026. 1,095 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Eagle Strategies held 3,232 shares of Gilead Sciences worth $408K as of Q2 2026.
  • Eagle Strategies bought 33 Gilead Sciences shares in Q2 2026, an estimated $4.35K.
  • Gilead Sciences made up 0.04% of Eagle Strategies's portfolio in Q2 2026, its #207 holding.
  • Eagle Strategies first reported a position in Gilead Sciences in Q4 2022 and has held it in 14 quarters since.
  • Eagle Strategies's Gilead Sciences position peaked at $446K in Q1 2026.
  • 1,095 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Eagle Strategies's 13F filing for Q2 2026, filed 21 Jul 2026.